Carisoprodol

Specifications

78-44-4CAS Number

201-118-7EC Number

[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamateIUPAC Name

C12H24N2O4Chemical Formula

260.33 g/molMolecular Weight

carisoprodol; 78-44-4; Isomeprobamate; Carisoprodate; SOMA; Carisoprodatum; Carisoma; Isobamate; Isoprothane; Sanoma; Flexartal; Isoprotane; Miolisodal; Atonalyt; Isopropyl meprobamate; Nospasm; Relasom; Skutamil; Somalgit; Somanil; Apesan; Mioril; Caprodat; Isoprotan; Izoprotan; Somadril; Arusal; Carisol; Diolene; Domarax; Flexal; RELA; Carlsoma; Carlsoprol; Carsodal; Mediquil; Stialgin; Brianil; Calenfa; Carisoprodolum; Carsodol; Listaflex; Tonolyt isopropyl meprobamate; Isopropylmeprobamate; NCI-C56235; Carisoprodol civ; SCH 7307; DTXSID8024733; CB 8019; 2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate; [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate; NSC-172124; (1-Methylethyl)carbamic acid 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester; Isopropylcarbamic acid, ester with 2-(hydroxymethyl)-2-methylpentyl carbamate; N-Isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate; Carbamic acid, ester with 2-methyl-2-propyl-1,3-propanediol isopropylcarbamate; Carbamic acid, isopropyl-, 2-(hydroxymethyl)-2-methylpentyl ester carbamate (ester); Carbamic acid, (1-methylethyl)-, 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester; CHEBI:3419; DTXCID904733; 21925K482H; (+-)-2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate; Carbamic acid, ester with 2-(hydroxymethyl)-2-methylpentyl isopropylcarbamate; NSC172124; 2-methyl-2-propyltrimethylene carbamate isopropylcarbamate; N-isopropy-2-methyl-2-propyl-1,3-propanediol dicarbamate; Carbamic acid 2-isopropylcarbamoyloxymethyl-2-methyl-pentyl ester; Carbamic acid, (1-methylethyl)-, 2-[[(aminocarbonyl)oxy]methyl]-2-methylpentyl ester; (2-(carbamoyloxymethyl)-2-methylpentyl) N-propan-2-ylcarbamate; (RS)-2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl isopropylcarbamate; (RS)-2-{[(aminocarbonyl)oxy]methyl}-2-methylpentyl isopropylcarbamate; Carisoprodol Tablets; RefChem:54722; M03BA02; Carisoprodol Tablets, USP, 350 mg; 2-((carbamoyloxy)methyl)-2-methylpentyl N-(propan-2-yl)carbamate; 201-118-7; Mioratrina; Carlsodol; Mioriodol; Miolisodol; Carisoprodolum [INN-Latin]; Flexartel; MLS000028401; Artifar; Caridolin; Chinchen; Fibrosona; Flexagilt; Flexagit; Flexidon; Meprodat; Neotica; Muslax; Scutamil-C; MFCD00057661; 2-((Carbamoyloxy)methyl)-2-methylpentyl isopropylcarbamate; NCGC00015278-09; SMR000058433; Carisoprodolo [DCIT]; Carisoprodolo; Prazolamine; 2-[(carbamoyloxy)methyl]-2-methylpentyl propan-2-ylcarbamate; (+/-)-2-methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate; Carbamic acid, ester with 2-(hydroxymethyl)-2-methylpentylisopropyl carbamate; Carisoprodol (1.0mg/ml in Methanol); CCRIS 4764; HSDB 3021; SR-01000000076; EINECS 201-118-7; NSC 172124; BRN 1791537; 2-[(Carbamoyloxy)methyl]-2-methylpentyl isopropylcarbamate; Carisoprodol [USP:INN:BAN]; CAS-78-44-4; Prestwick_50; UNII-21925K482H; Soma (TN); Spectrum_000102; Opera_ID_1100; Prestwick0_000423; Prestwick1_000423; Prestwick2_000423; Prestwick3_000423; Spectrum2_001153; Spectrum3_000328; Spectrum4_000265; Spectrum5_000661; CARISOPRODOL [MI]; CARISOPRODOL [INN]; CARISOPRODOL [JAN]; 1,3-Propanediol, 2-methyl-2-propyl-, carbamate isopropylcarbamate (ester); CARISOPRODOL [HSDB]; CARISOPRODOL [VANDF]; CHEMBL1233; Lopac0_000319; SCHEMBL33286; BSPBio_000406; BSPBio_001935; CARISOPRODOL [MART.]; KBioGR_000730; KBioSS_000542; MLS001148409; MLS002454391; orb341972; CARISOPRODOL [WHO-DD]; DivK1c_000816; SPECTRUM1500162; Carisoprodol (JAN/USP/INN); SPBio_001105; SPBio_002345; BPBio1_000448; GTPL7610; DEA No. 8192; HMS502I18; KBio1_000816; KBio2_000542; KBio2_003110; KBio2_005678; KBio3_001155; CARISOPRODOL CIV [USP-RS]; Carisoprodol, 1mg/ml in Methanol; NINDS_000816; [2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate; CARISOPRODOL [EP IMPURITY]; CARISOPRODOL [ORANGE BOOK]; HMS1569E08; HMS1920K03; HMS2091A06; HMS2096E08; HMS2234F13; HMS3259O15; HMS3372H19; HMS3713E08; Pharmakon1600-01500162; HY-B1380; QYB60282; TYB91170; Carisoprodol (1 mg/ml in Methanol); CARISOPRODOL [USP MONOGRAPH]; Carisoprodol 1.0 mg/ml in Methanol; Tox21_110122; Tox21_200623; AC-212; CCG-40092; NSC756671; AKOS015842914; Tox21_110122_1; WLN: ZVO1X3&1&1OVMY1&1; CS-4819; DB00395; FM19816; LP00319; NC00502; NSC-756671; SDCCGSBI-0050307.P005; IDI1_000816; NCGC00015278-03; NCGC00015278-04; NCGC00015278-05; NCGC00015278-06; NCGC00015278-07; NCGC00015278-08; NCGC00015278-11; NCGC00015278-12; NCGC00015278-14; NCGC00015278-15; NCGC00089734-02; NCGC00089734-03; NCGC00089734-04; NCGC00089734-05; NCGC00089734-06; NCGC00089734-07; NCGC00258177-01; SBI-0050307.P004; SOMA COMPOUND COMPONENT CARISOPRODOL; AB00051932; C3573; EU-0100319; NS00008741; ST51037205; Carbamic acid,3-propanediol isopropylcarbamate; C 8759; C07927; D00768; N-Isopropyl-2-methyl-2-propyl-1, dicarbamate; AB00051932_15; CARISOPRODOL COMPOUND COMPONENT CARISOPRODOL; Q416905; SR-01000000076-2; SR-01000000076-4; SR-01000000076-6; W-104280; 1, 2-methyl-2-propyl-, carbamate isopropylcarbamate; BRD-A99939097-001-24-2; N-Isopropyl-2-methyl-2-propyl-1,3-propanediol, dicarbamate; Carisoprodol, European Pharmacopoeia (EP) Reference Standard; 1,3-Propanediol, 2-methyl-2-propyl-, carbamate isopropylcarbamate; 2-methyl-2-{[N-(methylethyl)carbamoyloxy]methyl}pentyl aminooate; Carisoprodol, United States Pharmacopeia (USP) Reference Standard; Carbamic acid, isopropyl-, 2-(hydroxymethyl)-2-methylpentyl ester carbamate; 1-Methylethylcarbamic acid 2-{[(aminocarbonyl)oxy]methyl}-2 -methylpentyl ester; Carbamic acid, isopropyl-, 2-(hydroxymethyl)-2-methylpentyl ester, carbamate; Carisoprodol;Domarax;N-Isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate; N-Isopropyl 2-methyl-2-propyl-1,3-propanediol dicarbamate; Isopropylcarbamic acid ester with 2-(hydroxymethyl)-2-methylpentyl carbamateSynonyms